Determining a role for Patient and Public Involvement and Engagement (PPIE) in genomic data governance for cancer care
Sahan K. et al, (2025), European Journal of Human Genetics
The value of large-scale programmes in human genomics
Horn R. et al, (2025), European Journal of Human Genetics
Technologies Do Not Build Trust, People Do: A Critical Response to Promises of Trust in Biobanking Through Blockchain and Generative AI
Samuel G. et al, (2025), The American Journal of Bioethics, 25, 130 - 132
The research relationship: participant perspectives on consent in biobanking.
Thompson R. et al, (2025), BMC medical ethics, 26
Uptake, utility and resource requirements of a genetic counselling telephone helpline within the BRCA-DIRECT digital pathway for mainstreamed BRCA testing in patients with breast cancer.
Torr B. et al, (2025), Journal of medical genetics
Development of a digital risk-prediction tool based on family health history for the general population: legal and ethical implications.
Dijkstra T. et al, (2024), Journal of community genetics
Ethical considerations in prenatal genomic testing
Horn R. et al, (2024), Best Practice & Research Clinical Obstetrics & Gynaecology, 97, 102548 - 102548
Classification of variants of reduced penetrance in high-penetrance cancer susceptibility genes: Framework for genetics clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group-UK).
Garrett A. et al, (2024), Genetics in medicine : official journal of the American College of Medical Genetics, 27
The PS4-likelihood ratio calculator: flexible allocation of evidence weighting for case-control data in variant classification.
Rowlands CF. et al, (2024), Journal of medical genetics
Balancing the rights of the pre-symptomatic child to be found with the risk of harm to others from the screening process.
Lucassen A. and Horton R., (2024), Eur J Hum Genet
Ethical and social implications of public-private partnerships in the context of genomic/big health data collection.
Horn R. et al, (2024), European journal of human genetics : EJHG, 32, 736 - 741
Why digital innovation may not reduce healthcare's environmental footprint.
Samuel G. et al, (2024), BMJ (Clinical research ed.), 385
Discussion of off-target and tentative genomic findings may sometimes be necessary to allow evaluation of their clinical significance.
Horton RH. et al, (2024), Journal of medical ethics, 50, 295 - 298
Focusing attention on physicians' climate-related duties may risk missing the bigger picture: towards a systems approach to health and climate.
Samuel G. et al, (2024), Journal of medical ethics, 50, 380 - 381
Predictive genetic testing for Huntington's disease: Exploring participant experiences of uncertainty and ambivalence between clinic appointments.
Ballard LM. et al, (2024), Journal of genetic counseling
Systematic reanalysis of genomic data by diagnostic laboratories: a scoping review of ethical, economic, legal and (psycho)social implications.
van der Geest MA. et al, (2024), European journal of human genetics : EJHG, 32, 489 - 497
Advocating for a Context Specific Approach to Tackle Inequities.
Samuel G. et al, (2024), The American journal of bioethics : AJOB, 24, 109 - 111
Challenges of using whole genome sequencing in population newborn screening.
Horton R. et al, (2024), BMJ (Clinical research ed.), 384
Genomic Data: Building Blocks for Life or Abstract Art?
Horton R. et al, (2024), Frontiers for Young Minds, 12